|
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
|
2R42CA203456-02A1
|
$999,501
|
|
MARATHI, UPENDRA
|
7 HILLS PHARMA, LLC
|
|
Image-guided ultrasound ablation for precision targeting of prostate cancer
|
1R01CA230323-01
|
$580,217
|
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Synergistic co-targeting of pro-apoptotic BAX and anti-apoptotic BCL-XL in cancer
|
1F31CA236434-01
|
$44,524
|
|
LOPEZ-ARROYO, ANDREA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
|
5R01CA218429-02
|
$1,347,851
|
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Next Generation of HPV and Cervical Cancer Research in HIV+ Women
|
1R01CA230331-01
|
$670,295
|
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
5R44CA183362-03
|
$789,107
|
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
6R44CA156740-05
|
$999,919
|
|
RHODE, PETER
|
ALTOR BIOSCIENCE. LLC
|
|
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues
|
1R43CA236097-01
|
$300,000
|
|
LIM, MARK
|
AMBERGEN, INC
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
3U24CA180803-05S1
|
$335,460
|
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-05
|
$307,736
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer-associated fibroblast in the regulation of bladder cancer stem cells
|
3R01CA175397-05S1
|
$110,950
|
|
CHAN, KEITH SYSON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer
|
5R03CA212816-02
|
$79,250
|
|
KAIPPARETTU, BENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Risk Stratification for and Early Detection of Liver Cancer
|
1U01CA230997-01
|
$732,726
|
|
KANWAL, FASIHA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting aberrant promoter DNA methylation for anticancer therapy
|
1R21CA229727-01
|
$182,700
|
|
SHEN, LANLAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
|
5U01CA214254-02
|
$1,020,224
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Cancer Metabolism Training Program
|
1T32CA221709-01A1
|
$201,444
|
|
ANN, DAVID
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia
|
5R00CA197498-05
|
$249,000
|
|
CHEN, CHUN-WEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Improving Patient-Centered Communication and Cancer Care
|
5R25CA174627-05
|
$264,960
|
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Optimizing Busulfan: Efficacy Toxicity and Pharmacometabolomics
|
5R01CA182963-06
|
$515,038
|
|
MCCUNE, JEANNINE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combined breast MRI/biomarker strategies to identify aggressive biology
|
3U01CA189283-04S1
|
$190,203
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combined breast MRI/biomarker strategies to identify aggressive biology
|
5U01CA189283-04
|
$663,841
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cytology-Free POC Cervical Cancer Diagnostics for Global Health
|
4UH3CA202663-03
|
$344,918
|
|
WEIDEMAIER, KRISTIN
|
BECTON, DICKINSON AND COMPANY
|
|
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
|
1R01CA229784-01
|
$667,694
|
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A National Curriculum in Cancer Genomics for Residents and Medical Students
|
5R25CA168544-07
|
$231,248
|
|
HASPEL, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Identification of Plasma- and Exosome-Based Protein Biomarkers for Early Detection of Pancreatic Cancer Using SOMAscan Technology
|
1R21CA218960-01A1
|
$228,375
|
|
LIBERMANN, TOWIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
|
5K01CA222707-02
|
$114,242
|
|
TRINH, BON
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.
|
5R44CA203068-03
|
$993,966
|
|
BERTENSHAW, GREG
|
BIOMARKER STRATEGIES, LLC
|
|
Cohesin Mutations in Acute Myelogenous Leukemia
|
5R01CA204231-02
|
$390,712
|
|
RAO, SRIDHAR
|
BLOODCENTER OF WISCONSIN, INC.
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level
|
1R33CA223581-01A1
|
$390,880
|
|
CHENG, JI-XIN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Understanding the mechanisms of immune suppression in lymph node metastases
|
1K22CA230315-01
|
$200,880
|
|
JONES, DENNIS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Pathogenesis and Treatment of NUT-Midline Carcinoma
|
3R01CA124633-11A1S1
|
$260,820
|
|
FRENCH, CHRISTOPHER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Clinical Genome Resource
|
3U41HG006834-05S1
|
$75,000
|
|
REHM, HEIDI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Spatiotemporal delivery of synergistic drug combinations to kidney cancer
|
1R01CA229772-01
|
$360,930
|
|
SABBISETTI, VENKATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating degradation as a therapeutic strategy against the Pseudo-kinase KSR
|
4K00CA212229-03
|
$74,196
|
|
BONDESON, DANIEL
|
BROAD INSTITUTE, INC.
|
|
Promoting Physical Activity in Latinas via Interactive Web-based Technology
|
5R01CA159954-06
|
$583,285
|
|
MARCUS, BESS
|
BROWN UNIVERSITY
|
|
Characterizing a new antibody targeting growth-arrested breast cancer cells
|
1R03CA230840-01
|
$80,000
|
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
|
1R01CA217992-01A1
|
$366,000
|
|
KHALIL, AHMAD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Novel Bi-functional Inhibitors Blocking OncomiR Biogenesis
|
7R21CA202831-04
|
$229,837
|
|
LIANG, FU-SEN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
|
5R01CA196687-04
|
$522,225
|
|
MUZIC, RAYMOND
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining the Super-Enhancer Landscape in Triple Negative Breast Cancer Subtypes
|
5F31CA224809-02
|
$48,883
|
|
WEBB, BRYAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model
|
1R01CA222064-01A1
|
$412,584
|
|
ZHOU, LAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Prostate Cancer Bone Metastasis Biology and Targeting
|
3P01CA098912-14S1
|
$18,678
|
|
CHUNG, LELAND
|
CEDARS-SINAI MEDICAL CENTER
|
|
Prostate Cancer Bone Metastasis Biology and Targeting
|
3P01CA098912-14S2
|
$12,477
|
|
CHUNG, LELAND
|
CEDARS-SINAI MEDICAL CENTER
|
|
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
|
5R01CA182438-05
|
$548,878
|
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
Development of IG7 as an enhancer of anti-PD-1 cancer immunotherapy
|
1R43CA221414-01A1
|
$202,500
|
|
LU, CHUNWAN
|
CHEMEDIMMUNE, INC.
|
|
Targeting the GPC2 oncoprotein with immune-based therapies in neuroblastoma
|
1K08CA230223-01
|
$202,195
|
|
BOSSE, KRISTOPHER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
|
5R35CA220500-02
|
$1,032,000
|
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Total relevant funding to Pesticides for this search: $2,503,328
|